Outcome Modifying Genes in Sickle Cell Disease | NHLBI Trans-Omics for Precision Medicine Skip to main content

Outcome Modifying Genes in Sickle Cell Disease

Short Name
OMG_SCD
Institution(s)
Duke University
Type of Omics
WGS
Approx. Sample Size 675
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
TOPMed Accession #
phs001608
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above
7.1
Omics Center Contact
Donna Muzny
Phases Involved
2
PI

Allison Ashley-Koch
Co-PI
Marilyn Telen
Contact

Allison Ashley-Koch
Data Set contact(s)
Allison Ashley-Koch
Marilyn Telen
COL Contact(s)
Allison Ashley-Koch
Marilyn Telen
Project
OMG_SCD